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Introduction
Infections encountered in the ﬁeld of obstetrics and gyne-
cology have unique features, including some infections
which can result in serious future problems (e.g., sterility).
Bacteria and other microbes constituting the indigenous
bacterial ﬂora of the vagina (a component of the lower
genital system), such as anaerobes, are often responsible
for female genital infections. The prevalence of intractable
infections dependent on host factors has been increasing.
Types of infections encountered in the ﬁeld of obstetrics
and gynecology
Infections in the ﬁeld of obstetrics and gynecology can be
roughly divided into those of the internal genitalia, infec-
tions of the external genitalia, vaginitis, cervicitis, urinary
tract infection, perinatal infection, perioperative infection
(postoperative infections), sexually transmitted diseases
(STD), and so on. Infection of internal genitalia is a general
term for inﬂammation of the internal genitalia and connec-
tive tissue, encompassing intrauterine infection, adnexitis,
pelvioperitonitis, Douglas pouch abscess, parametritis, and
so on. Most infections of the internal genitalia assume the
form of an ascending infection; infection within the uterus
usually leads to adnexitis, and adnexitis tends to progress
into pelvioperitonitis. For this reason, infections of the
internal genitalia are nowadays collectively referred to as
‘‘pelvic inﬂammatory disease (PID).’’ Among infections of
external genitalia, bartholinitis, Bartholin’s abscess, vulvitis
and vulvar abscess are known. Vulvitis and vulvar abscess
are often managed at departments of dermatology or surgery
as well. Perinatal infections include chorioamnionitis during
pregnancy and puerperal intrauterine infection, puerperal
mastitis, neonatal Group B Streptococcus (GBS) infection,
and so on. Perioperative infections can be divided into
surgery-related infection (surgical site infection: SSI) and
surgery-unrelated infection (infection of non-surgical sites).
Surgery-related infections include superﬁcial/deep inci-
sional infection and organ/space related infection (intra-
peritoneal abscess, etc.). Surgery-unrelated infections
include sepsis, respiratory tract infection, intravascular
catheter infection, pseudomembranous enteritis, MRSA
enteritis, urinary tract infection, and so on.
Most female genital infections can be characterized by
the frequent involvement of anaerobes which cause mixed
infections in combination with aerobes and other microbes.
Microbes responsible for obstetric/gynecologic
infections
Table 1 lists major microorganisms responsible for infec-
tions encountered in the ﬁeld of obstetrics and gynecology.
Excluding microbes related to sexually transmitted dis-
eases, the pathogens for obstetric/gynecologic infections
are often members of the normal vaginal microbial ﬂora
which include anaerobes as well.
Obstetric infections involving anaerobes
Pathogenesis
Chorioamnionitis is a representative obstetric infection in
which anaerobes are involved. In the ﬁrst trimester of
pregnancy, this disease can lead to threatened abortion. In
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the second trimester and later in pregnancy, it can cause
preterm rupture of membranes (PROM) and threatened
abortion.
Diagnosis
Chorioamnionitis can be divided into clinical and histo-
logical forms. The clinical form of chorioamnionitis is
usually diagnosed by clinicians and the diagnosis is based
on the criteria shown in Table 2. As a practical matter, it is
difﬁcult to make a diagnosis of chorioamnionitis clinically
in women facing PROM, and the accuracy of such a
diagnosis, if made, is not high. For this diagnosis, amniotic
ﬂuid tests and the like, combined with hematological tests,
etc., are sometimes needed. Histological chorioamnionitis,
on the other hand, is diagnosed on the basis of
Table 1 Major pathogens for
obstetric/gynecologic infections
Aerobes
Enterococcus spp. (E. faecalis, E. faecium, etc.)
Staphylococcus spp. (S. epidermidis, S. aureus, etc.)
Streptococcus spp. (S. agalactiae, S. pyogenes, etc.)
Gardnerella vaginalis
Neisseria gonorrhoeae
Escherichia spp. (E. coli)
Klebsiella spp. (K. pneumoniae, K. oxytoca, etc.)
Proteus spp. (P. mirabilis, P. vulgaris, etc.)
Enterobacter spp. (E. cloace, E. aerogenes, etc.)
Citrobacter spp. (C. freundii, etc.)
Morganella spp. (M. morganii, etc.)
Serratia spp. (S. marcescens, etc.)
Pseudomonas spp. (P. aeruginosa, etc.)
Burkholderia spp. (B. cepacia, etc.)
Anaerobes
Peptostreptococcus sp. (P. anaerobius)
Finegoldia spp. (F. magna, etc.)
Parvimonas spp. (P. micra, etc.)
Peptoniphilus spp. (P. asaccharolyticus, etc.)
Anaerococcus spp. (A. prevotii, etc.)
Actinomyces spp. (A. israelii, etc.)
Propionibacterium spp. (P. acnes, etc.)
Eggerthella spp. (E. lenta, etc.)
Mobiluncus spp. (M. mulieris, M. curtisii subspecies curtisii, M. curtisii subspecies holmesii, etc.)
Atopobium spp. (A. vaginae, etc.)
Veillonella spp. (V. parvula, etc.)
Bacteroides spp. (B. fragilis, B. thetaiotaomicron, B. distasonis, B. ovatus, B. uniformis, B. vulgatus, etc.)
Prevotella spp. (P. bivia, P. disiens, P. intermedia, P. loescheii, P. melaninogenica, etc.)
Porphyromonas spp. (P. asaccharolytica, etc.)
Fusbacterium spp. (F. nucleatum, etc.)
Clostridium spp. (C. perfringens, C. difﬁcile, etc.)
Spirochetes
Treponema spp. (T. pallidum)
Mycoplasmas
Mycoplasma spp. (M. hominis, M. genitalium, etc.)
Ureaplasmas
Ureaplasma spp. (U. parvum biovar 1, U. urealyticum biovar 2, etc.)
Chlamydiaceae
Chlamydia spp. (C. trachomatis)
Fungi
Candida spp. (C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei, etc.)
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histopathological examination of the placenta. Its severity
depends on the degree of neutrophil inﬁltration of the
chorion and amniotic sac. The Blanc classiﬁcation is
widely used for this purpose. Depending on the degree of
leukocyte inﬁltration, this disease is rated as stage I, II or
III. Diagnosis is possible only by postnatal pathological
examination, i.e. not before delivery.
Chorioamnionitis mostly develops as a secondary dis-
ease arising from ascending infection associated with
bacterial vaginosis. It is rational to consider anaerobes to
often be involved in this condition.
Treatment
In granulocyte elastase positive cases and oncofetal ﬁbro-
nectin positive cases, the following antimicrobial agents
which are stable against b-lactamase and to which
anaerobes are highly susceptible are selected, while care is
taken to detect any changes in inﬂammation markers (CRP,
etc.): penicillins with b-lactamase inhibitors, cephamycins
(including oxa-type), cefems with b-lactamase inhibitors,
carbapenems, clindamycin (CLDM), etc [1]. One charac-
teristic of b-lactams, as compared to macrolides, is better
transfer from the mother to the fetus. If signs of threatened
abortion or premature labor are noted, hospitalization is
needed. If ﬁbronectin or inﬂammation markers are positive,
uterine contraction inhibitors or urinastatin is administered
in combination with other drugs. If polyps are found in the
uterine cervix, it is desirable to resect them because they are
likely to be complicated by infection. Diseases accompa-
nied by external bleeding (e.g., subchorionic hematoma)
can precipitate ascending infection and thus necessitate
vaginal cleansing and treatment with antibacterial vaginal
tablets [chloramphenicol (CP), metronidazole, etc.].
Table 2 Diagnosis of clinical chorioamnionitis
1. Fever, maternal tachycardia (over 100/min) or fetal tachycardia, uterine tenderness, uterine contraction, and malodorous amniotic ﬂuid.
2. Leftward shift of leukocytes (WBC over 12,000–15,000/mm3), elevated CRP, elevated granulocyte elastase, elevated oncofetal ﬁbronectin,




Gram-staining of microbial test 
sample (to determine whether the 
pathogen is gram-positive or 
gram-negative and whether the 
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- Uterine contents (bacteriological tests, including a 
check for anaerobes)
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Review of diagnosis, 
switching antimicrobial 
agents
Selection of antimicrobial agents 








Fig. 1 Guidelines for the diagnosis and treatment of pelvic inﬂammatory disease (PID)
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Gynecologic infections involving anaerobes
Representative PIDs include endometritis, intrauterine
infection (myometritis, etc.), pyometra, adnexitis, para-
metritis, pelvioperitonitis, Douglas pouch abscess, and so
on. They usually assume the form of ascending infection
from the vulva, vagina or cervix [2–7].
Morbid conditions
Endometritis
Endometritis is a condition in which the usually aseptic
endometrium is inﬂamed. This infection can be divided
into puerperal and non-puerperal types.
Puerperal endometritis can develop after delivery
spontaneous or induced abortion. It follows an acute course
and is precipitated by the partially remaining placenta or
egg membrane or by intrauterine manipulation. This
infection is ascending in nature and is caused by Staphy-
lococcus spp., Streptococcus spp., Escherichia coli, etc.
Not a few cases of puerperal endometritis assume the form
of mixed infections, involving anaerobes [8].
Non-puerperal endometritis is an acute inﬂammation
caused by endometrial curettage, hysterosalpingography,
insertion of an intrauterine device (IUD), radiotherapy
and so on. Gonococcal endometritis is also acute in nature
[9]. Tuberculous endometritis is a descending trans-
infection via the oviduct or blood-borne infection sec-
ondary to tuberculous peritonitis, etc. It is chronic in
nature in most cases. Pyometra indicates a condition in
which pus has pooled within the uterine cavity due to
obstruction of the oviductal stroma and internal oriﬁce of
the uterus and subsequent infection caused by aging-
related cervical atrophy, malignant invasion of the uterine
body, atrophy of the cervix after radiotherapy for cervical
carcinoma, and so on. Particular care is needed with
intrauterine infection caused by long-term IUD insertion,
since anaerobic bacteria of Actinomyces spp. may be
isolated from such cases.
Chronic endometritis associated with sexually trans-
mitted diseases has recently been highlighted. Endometritis
is sometimes detected in cases on whom the presence of
Neisseria gonorrhoeae or Chlamydia spp. has been
established.
Frequent pathogens for this condition are aerobes,
anaerobes and b-lactamase-producing bacteria.
Adnexitis
Adnexitis is the most frequent infection of the internal
genitalia. It often affects the oviduct as well as the
adjoining ovaries.
Pathogens for this infection include aerobic gram-neg-
ative rods, aerobic gram-positive cocci, Neisseria gonor-
rhoeae, anaerobes, Chlamydia spp., Mycoplasma spp.,
Ureaplasma spp., and occasionally fungi (Candida spp.).
This infection often assumes a mixed form [8]. Adnexitis is
mostly an ascending infection from the vagina. Adnexitis,
assuming the form of a descending infection from intra-
pelvic infectious foci, occurs secondary to appendicitis,
etc., but at a low incidence.
In patients with cancer and other patients, adnexitis is
sometimes caused by translocation from the intestine.
Tuberculous salpingitis is a blood-borne infection. It is
precipitated by abortion, delivery, intrauterine manipula-
tion (intrauterine cleaning), IUD insertion, hysterosalpin-
gography, sexual intercourse and so on.
Frequent pathogens for adnexitis are aerobes, anaerobes
and b-lactamase-producing bacteria.
Parametritis
Parametritis means extensive inﬂammation of the connec-
tive tissue located between the pelvic wall or pelvic ﬂoor
fascia and pelvic peritoneum within the pelvis minor and
ﬁlling the spaces surrounding the uterus, urinary bladder,
rectum, etc. Unlike intra-pelvic infection, parametritis is
extraperitoneal (particularly retroperitoneal) inﬂammation.
This infection is likely to be caused by injury of the birth
canal during labor, injury (e.g., cervical tear) during
spontaneous or induced abortion, total hysterectomy,
intense inﬁltration of the parauterine connective tissue by a
malignant tumor, and so on. This infection sometimes
develops secondary to inﬂammation of nearby organs
(urinary bladder, rectum, etc.) in a contiguous or blood-
borne manner.
Pelvioperitonitis
Pelvioperitonitis is localized peritonitis arising in the
parietal and/or visceral peritoneum within the pelvis minor.
This infection is often secondary to endometritis and
adnexitis. It is sometimes secondary to rupture of the
digestive organ (rupture of an inﬂamed appendix, etc.).
Once it develops, adnexitis is likely to spread to sur-
rounding tissue. It is therefore advisable to consider this
disease to often be complicated to some extent by
pelvioperitonitis.
Diagnosis
Figure 1 shows a ﬂow chart for the diagnosis and treatment
of PID.
Because PID is a bacterial infection of the upper genital
tract, its incidence is higher in sexually active women.
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Patients with PID often consult departments of internal
medicine and so on, instead of the department of obstetrics
and gynecology. Because abdominal X-ray, CT scans, etc.,
are often used to diagnose PID, it is essential to rule out
pregnancy before conducting these tests.
Treatment
Because PID often involves anaerobes, obtaining culture
results is time-consuming. Therefore, the response to gram
staining is very important for selecting empiric therapy.
Stated concretely, extremely valuable information for the
selection of appropriate antimicrobial agents is obtained by
examining whether the pathogen is gram-positive or gram-
negative and whether the pathogen is a coccus or a rod.
Furthermore, since culturing samples to check for anaerobes
often yields a negative result, gram staining is quite helpful.
If gram-stained samples have revealed gram-negative
diplococci, it is sometimes rational to strongly suspect the
patient to have Neisseria gonorrhoeae endometritis or the
like.
When collecting samples, it is essential to avoid con-
tamination with vaginal bacterial ﬂora as far as possible.
When dealing with cases suspected of having adnexitis,
efforts should be made to collect high quality samples with
minimal contamination, by providing adequate information
to the patient as to the necessity of Douglas pouch punc-
ture, and so on.
When dealing with PID, selection of oral administration
versus drip infusion of medicine should be based on the
severity of clinical symptoms. Generally, oral therapy is
possible if symptoms are mild to moderate. However, drip
infusion is recommended in severe cases, e.g., those in
whom lower abdominal pain or tenderness is intense and
inﬂammation has advanced to pelvioperitonitis or
peritonitis.
At the acute stage of PID, broad-spectrum antimicrobial
agents, also effective against anaerobes, are often used.
Practice of medication
Table 3 presents examples of medications used to treat
female genital infections.
Ciproﬂoxacin (CPFX) and pazuﬂoxacin (PZFX), which
are recently marketed injectable preparations of
Table 3 Examples of medications used for PID cases possibly involving anaerobes
1. Oral drug therapy for PID possibly involving anaerobes
(drip infusion is often used in cases in which anaerobes are primarily responsible)
(1) Clavulanic acid/amoxicillin (CVA/AMPC) (375 mg/dose, 3–4 doses/day)
(2) Sultamicillin (375 mg/dose, 2–3 doses/day)
(3) Faropenem (FRPM) (150–300 mg/dose, 3 doses/day)
(4) Moxiﬂoxacin (MFLX) (400 mg/dose, 1 dose/day, off-label use)
(5) Metronidazole (250–500 mg/dose, 4 doses/day, off-label use)
2. Drip infusion for PID possibly involving anaerobes
(1) Piperacillin (PIPC) (1–2 g/dose, 2–4 doses/day, 8 g per day at maximum)
(2) Tazobactam/piperacillin (TAZ/PIPC) (4.5 g/dose, 2–4 doses/day)
(3) Cefmetazole (CMZ) (1–2 g/dose, 2–4 doses/day, 4 g per day at maximum)
(4) Flomoxef (FMOX) (1–2 g/dose, 2–4 doses/day, 4 g per day at maximum)
(5) Imipenem/cilastatin (IPM/CS) (0.5–1 g/dose, 2–3 doses/day, 2 g per day at maximum)
(6) Panipenem/betamiprom (PAPM/BP) (0.5–1 g/dose, 2 doses/day, 2 g per day at maximum)
(7) Meropenem (MEPM) (0.5–1 g/dose, 2–3 doses/day, 2 g per day at maximum)
(8) Biapenem (BIPM) (0.3–0.6 g/dose, 2 doses/day, 1.2 g per day at maximum)
(9) Doripenem (DRPM) (0.25–0.5 g/dose, 2–3 doses/day, 1.5 g per day at maximum)
(10) Sulbactam/cefoperazone (SBT/CPZ) (1–2 g/dose, 2 doses/day, 4 g per day at maximum)
1. (4) is contraindicated for pregnant or possibly pregnant women. If (4) is used for lactating women, breast-feeding should be suspended. If (5) is
used to deal with a mixed infection involving aerobes, etc., as co-pathogens, treatment should be combined with a drug to which the predicted
pathogens are susceptible. (1) through (4) may be combined with Clindamycin (CLDM), Minocycline (MINO) or metronidazole depending on
the symptoms.
2. (1) through (10) may be combined with CLDM (300–600 mg/dose, 2–4 doses/day, 1,200 mg per day at maximum, i.v.), MINO (100–200 mg/
dose, 1–2 doses/day, 400 mg per day at maximum, i.v.) or metronidazole (250–500 mg/dose, 4 doses/day, oral, off-label use) depending on the
symptoms.
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ﬂuoroquinolones, show high blood levels after adminis-
tration and are well distributed in the target tissue. How-
ever, these drugs do not exert adequate activity against
anaerobes, and their use in combination with CLDM,
minocycline (MINO), etc., should be considered since
combined use may be effective against mixed infections
with aerobes plus anaerobes. At present, intravenous met-
ronidazole is not available in Japan for treatment of these
infections.
When dealing with pyometra, drainage should be per-
formed ﬁrst, followed by antibacterial chemotherapy. In
cases in which actinomycosis (e.g., infection with bacteria
of Actinomyces spp.) is suspected, penicillins should be
used.
Surgery is selected if pyosalpinx shows alleviation or
reduced inﬂammation in response to antimicrobial che-
motherapy or antimicrobial chemotherapy is ineffective
against pyosalpinx.
In severe cases, treatment should be administered based
on the PK–PD (pharmacokinetics–pharmacodynamics)
concept. When treating with b-lactams such as cephems
and carbapenems, increasing the daily dosing frequency
should be considered. If ﬂuoroquinolones are used,
increasing the single dose level should be considered.
In cases with possible involvement of Chlamydia spp.,
macrolides, tetracyclines or ﬂuoroquinolones are reason-
able drug choices. If pregnancy cannot be ruled out, mac-
rolides should be used.
Table 4 shows the principles applied in selecting anti-
microbial agents when dealing with gynecologic infectious
diseases.
To suppress the development of resistant bacteria, the
use of antimicrobial agents should be discontinued and the
patient followed closely after clinical symptoms (pyrexia,
lower abdominal pain, lower abdominal tenderness, etc.)
have been alleviated, as a rule.
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